Therapeutic Mechanism of Kynurenine, a Metabolite of Probiotics, on Atopic Dermatitis in Mice

Atopic Dermatitis (AD) is a common inflammatory skin disease characterized primarily by its chronic and recurrent nature. This has a significant impact on productivity and human longevity. Dysbiosis of gut flora has been demonstrated to be significantly associated with the progression of AD. In our...

Full description

Saved in:
Bibliographic Details
Main Authors: Yixuan Li, Mingxin Li, Qingyu Ren, Chunqing Ai, Shugang Li, Huan Li, Shouhao Zhao, Donglin Sui, Xiaomeng Ren
Format: Article
Language:English
Published: MDPI AG 2025-05-01
Series:Foods
Subjects:
Online Access:https://www.mdpi.com/2304-8158/14/10/1816
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849711309192429568
author Yixuan Li
Mingxin Li
Qingyu Ren
Chunqing Ai
Shugang Li
Huan Li
Shouhao Zhao
Donglin Sui
Xiaomeng Ren
author_facet Yixuan Li
Mingxin Li
Qingyu Ren
Chunqing Ai
Shugang Li
Huan Li
Shouhao Zhao
Donglin Sui
Xiaomeng Ren
author_sort Yixuan Li
collection DOAJ
description Atopic Dermatitis (AD) is a common inflammatory skin disease characterized primarily by its chronic and recurrent nature. This has a significant impact on productivity and human longevity. Dysbiosis of gut flora has been demonstrated to be significantly associated with the progression of AD. In our previous research, it was shown that <i>Lactobacillus rhamnosus</i> RL5-H3-005 (RL) and <i>Pediococcus acidilactici</i> RP-H3-006 (RP) have the ability to reduce the risk of disease in AD mice through the gut–mammary axis. Based on our previous work, this study aims to further investigate the effects of kynurenine (KYN), a metabolite of RL and RP, on AD mice induced by 2, 4-dinitrofluorobenzene (DNFB). In this study, we found that supplementing KYN in AD mice effectively alleviates the pathological symptoms of atopic dermatitis and further improves the levels of SCFAs in their intestines. Further research indicates that KYN’s therapeutic effects on AD are primarily manifested in the reduction of secretory immunoglobulin A (sIgA), immunoglobulin E (IgE), interleukin-4 (IL-4), IL-5, IL-13, and thymic stromal lymphopoietin (TSLP) levels in mice, while also repairing the intestinal barrier function of AD mice. Overall, the metabolites KYN of probiotics RL and RP can regulate the levels of SCFAs of mice, potentially improving the symptoms of AD mice through the gut–skin axis.
format Article
id doaj-art-e77d01f6bba943f3938d343771ef085f
institution DOAJ
issn 2304-8158
language English
publishDate 2025-05-01
publisher MDPI AG
record_format Article
series Foods
spelling doaj-art-e77d01f6bba943f3938d343771ef085f2025-08-20T03:14:39ZengMDPI AGFoods2304-81582025-05-011410181610.3390/foods14101816Therapeutic Mechanism of Kynurenine, a Metabolite of Probiotics, on Atopic Dermatitis in MiceYixuan Li0Mingxin Li1Qingyu Ren2Chunqing Ai3Shugang Li4Huan Li5Shouhao Zhao6Donglin Sui7Xiaomeng Ren8State Key Laboratory of Marine Food Processing and Safety Control, National Engineering Research Center of Seafood, School of Food Science and Technology, Dalian Polytechnic University, Dalian 116034, ChinaState Key Laboratory of Marine Food Processing and Safety Control, National Engineering Research Center of Seafood, School of Food Science and Technology, Dalian Polytechnic University, Dalian 116034, ChinaState Key Laboratory of Marine Food Processing and Safety Control, National Engineering Research Center of Seafood, School of Food Science and Technology, Dalian Polytechnic University, Dalian 116034, ChinaState Key Laboratory of Marine Food Processing and Safety Control, National Engineering Research Center of Seafood, School of Food Science and Technology, Dalian Polytechnic University, Dalian 116034, ChinaState Key Laboratory of Marine Food Processing and Safety Control, National Engineering Research Center of Seafood, School of Food Science and Technology, Dalian Polytechnic University, Dalian 116034, ChinaState Key Laboratory of Marine Food Processing and Safety Control, National Engineering Research Center of Seafood, School of Food Science and Technology, Dalian Polytechnic University, Dalian 116034, ChinaState Key Laboratory of Marine Food Processing and Safety Control, National Engineering Research Center of Seafood, School of Food Science and Technology, Dalian Polytechnic University, Dalian 116034, ChinaState Key Laboratory of Marine Food Processing and Safety Control, National Engineering Research Center of Seafood, School of Food Science and Technology, Dalian Polytechnic University, Dalian 116034, ChinaState Key Laboratory of Marine Food Processing and Safety Control, National Engineering Research Center of Seafood, School of Food Science and Technology, Dalian Polytechnic University, Dalian 116034, ChinaAtopic Dermatitis (AD) is a common inflammatory skin disease characterized primarily by its chronic and recurrent nature. This has a significant impact on productivity and human longevity. Dysbiosis of gut flora has been demonstrated to be significantly associated with the progression of AD. In our previous research, it was shown that <i>Lactobacillus rhamnosus</i> RL5-H3-005 (RL) and <i>Pediococcus acidilactici</i> RP-H3-006 (RP) have the ability to reduce the risk of disease in AD mice through the gut–mammary axis. Based on our previous work, this study aims to further investigate the effects of kynurenine (KYN), a metabolite of RL and RP, on AD mice induced by 2, 4-dinitrofluorobenzene (DNFB). In this study, we found that supplementing KYN in AD mice effectively alleviates the pathological symptoms of atopic dermatitis and further improves the levels of SCFAs in their intestines. Further research indicates that KYN’s therapeutic effects on AD are primarily manifested in the reduction of secretory immunoglobulin A (sIgA), immunoglobulin E (IgE), interleukin-4 (IL-4), IL-5, IL-13, and thymic stromal lymphopoietin (TSLP) levels in mice, while also repairing the intestinal barrier function of AD mice. Overall, the metabolites KYN of probiotics RL and RP can regulate the levels of SCFAs of mice, potentially improving the symptoms of AD mice through the gut–skin axis.https://www.mdpi.com/2304-8158/14/10/1816gut microbiotaoxidant stresstryptophan metabolism
spellingShingle Yixuan Li
Mingxin Li
Qingyu Ren
Chunqing Ai
Shugang Li
Huan Li
Shouhao Zhao
Donglin Sui
Xiaomeng Ren
Therapeutic Mechanism of Kynurenine, a Metabolite of Probiotics, on Atopic Dermatitis in Mice
Foods
gut microbiota
oxidant stress
tryptophan metabolism
title Therapeutic Mechanism of Kynurenine, a Metabolite of Probiotics, on Atopic Dermatitis in Mice
title_full Therapeutic Mechanism of Kynurenine, a Metabolite of Probiotics, on Atopic Dermatitis in Mice
title_fullStr Therapeutic Mechanism of Kynurenine, a Metabolite of Probiotics, on Atopic Dermatitis in Mice
title_full_unstemmed Therapeutic Mechanism of Kynurenine, a Metabolite of Probiotics, on Atopic Dermatitis in Mice
title_short Therapeutic Mechanism of Kynurenine, a Metabolite of Probiotics, on Atopic Dermatitis in Mice
title_sort therapeutic mechanism of kynurenine a metabolite of probiotics on atopic dermatitis in mice
topic gut microbiota
oxidant stress
tryptophan metabolism
url https://www.mdpi.com/2304-8158/14/10/1816
work_keys_str_mv AT yixuanli therapeuticmechanismofkynurenineametaboliteofprobioticsonatopicdermatitisinmice
AT mingxinli therapeuticmechanismofkynurenineametaboliteofprobioticsonatopicdermatitisinmice
AT qingyuren therapeuticmechanismofkynurenineametaboliteofprobioticsonatopicdermatitisinmice
AT chunqingai therapeuticmechanismofkynurenineametaboliteofprobioticsonatopicdermatitisinmice
AT shugangli therapeuticmechanismofkynurenineametaboliteofprobioticsonatopicdermatitisinmice
AT huanli therapeuticmechanismofkynurenineametaboliteofprobioticsonatopicdermatitisinmice
AT shouhaozhao therapeuticmechanismofkynurenineametaboliteofprobioticsonatopicdermatitisinmice
AT donglinsui therapeuticmechanismofkynurenineametaboliteofprobioticsonatopicdermatitisinmice
AT xiaomengren therapeuticmechanismofkynurenineametaboliteofprobioticsonatopicdermatitisinmice